Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Cardiology

Living Well with HCM: Exercise, Monitoring, and Wellness

At a Glance

Living with Hypertrophic Cardiomyopathy no longer means strict exercise restriction. New medical guidelines encourage personalized, moderate physical activity. Safely managing HCM involves regular cardiac monitoring, staying well-hydrated, and addressing the psychological impacts of the condition.

Living with Hypertrophic Cardiomyopathy (HCM) is a long-term journey that requires a shift in how you think about your body and your health. In the past, patients were often told to avoid all strenuous activity. Today, thanks to a major paradigm shift in medical guidelines, the focus has moved from restriction to “shared decision-making” and personalized activity [1][2].

A New Era for Exercise

The 2024 AHA/ACC guidelines have fundamentally changed how doctors approach physical activity for HCM patients [1][3].

  • From Restrictive to Personalized: For decades, “no sports” was the standard advice. Now, research shows that structured, moderate exercise is not only safe but beneficial for your heart health and fitness [2][4].
  • Competitive Sports: For the first time, even high-intensity or competitive sports may be an option for some patients [2][5]. This is a highly individualized decision that depends on your specific risk factors, such as your history of fainting, your heart’s wall thickness, and whether you have extensive scarring or an apical aneurysm [1][6][7].
  • Finding Your Level: Your doctor may use a Cardiopulmonary Exercise Test (CPET) to see exactly how your heart responds to exertion and help you determine a safe heart rate zone for exercise [8][9].

The Surveillance Schedule: Watching Your Heart

Because HCM can change over time, regular “check-ups” for your heart are essential. While every patient is different, a stable HCM patient can typically expect the following surveillance schedule [10][11]:

Test Typical Frequency Purpose
Echocardiogram Every 1–2 years To check for changes in muscle thickness and monitor blood flow (gradients) [10][12].
Holter Monitor Every 1–2 years A 24- to 48-hour wearable monitor to check for “silent” irregular heart rhythms (NSVT) [13][14].
Cardiac MRI Every 3–5 years To track any increase in heart scarring (LGE) or the development of an apical aneurysm [10][15].
Clinical Exam Every 6–12 months A standard visit to discuss symptoms and adjust medications [3].

Daily Management Tips

Small habits can make a big difference in how you feel, especially if you have the obstructive form of HCM.

  • Hydration is Key: Dehydration makes the heart “empty,” which can cause the thickened muscle and mitral valve to obstruct blood flow more easily [16][17]. Aim to drink plenty of water throughout the day, especially in hot weather or during activity.
  • Avoid Overheating: Hot showers, saunas, or intense heat can cause your blood vessels to dilate, which may lower your blood pressure and worsen your symptoms [18].
  • Limit Alcohol and Large Meals: Both can occasionally trigger a spike in your heart’s gradient, making you feel more short of breath [18].

The Psychological Toll: “Scanxiety” and the ICD

Living with a chronic heart condition and a wearable or internal device can be mentally taxing.

  • Scanxiety: It is common to feel a spike in anxiety in the days leading up to your routine Echo or MRI. Acknowledging this “scanxiety” as a normal part of the HCM experience can help you manage it [19].
  • Living with an ICD: If you have an ICD, you might feel a mix of gratitude for the “safety net” and fear of a potential shock. Some patients find themselves avoiding activity out of fear the device will fire [20][21].
  • Seeking Support: If anxiety is limiting your life, consider “cardiac psychology”—a specialized field that helps patients navigate the emotional challenges of heart disease [19].

Your goal is to live a full, active life while staying within the “safety lanes” established by your care team. With modern monitoring and personalized exercise, most patients are able to do exactly that [1][2].

Return to Home

Common questions in this guide

Can I safely exercise if I have hypertrophic cardiomyopathy?
Yes, recent medical guidelines encourage structured, moderate exercise for most HCM patients. Your doctor may perform an exercise test to help determine a safe heart rate zone to create a personalized activity plan just for you.
Can I participate in high-intensity sports with HCM?
Under the 2024 guidelines, high-intensity or competitive sports may be an option for certain patients. This is a highly individualized decision based on your specific risk factors, heart wall thickness, and history of fainting.
How often will my heart need to be monitored with HCM?
A typical surveillance schedule for a stable patient includes an echocardiogram and Holter monitor every one to two years. You may also need a cardiac MRI every three to five years to track changes in the heart muscle and scarring.
Why is staying hydrated important for HCM?
Dehydration makes the heart less full of blood, which can worsen the obstruction of blood flow caused by the thickened heart muscle and mitral valve. Drinking plenty of water helps minimize this obstruction and reduces symptoms.
How can I manage the anxiety of having an ICD or waiting for test results?
Feeling anxiety about an implantable cardioverter defibrillator or upcoming scans is common and normal. Many patients benefit from working with a cardiac psychologist, who specializes in helping people navigate the emotional challenges of heart conditions.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What does a 'personalized' exercise plan look like for me based on my current wall thickness and LGE percentage?
  2. 2.Based on the 2024 guidelines, can I participate in high-intensity sports or competitive athletics?
  3. 3.What is our specific schedule for surveillance: how often will I need an Echo, a Holter monitor, and a repeat Cardiac MRI?
  4. 4.If I am feeling anxious about my heart or my ICD, can you refer me to a psychologist who specializes in 'cardiac-psychology'?
  5. 5.How much water should I be drinking daily to keep my heart 'full' and minimize my LVOT gradient?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

    Ommen SR, Ho CY, Asif IM, et al.

    Circulation 2024; (149(23)):e1239-e1311 doi:10.1161/CIR.0000000000001250.

    PMID: 38718139
  2. 2

    Redefining Management in Hypertrophic Cardiomyopathy: The Role and Challenges of Exercise Rehabilitation.

    Verma A, Anand A, Patel VA, et al.

    Cardiology in review 2024; doi:10.1097/CRD.0000000000000766.

    PMID: 39177404
  3. 3

    2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

    , Ommen SR, Ho CY, et al.

    Journal of the American College of Cardiology 2024; (83(23)):2324-2405 doi:10.1016/j.jacc.2024.02.014.

    PMID: 38727647
  4. 4

    Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy.

    Limongelli G, Monda E, D'Aponte A, et al.

    Heart failure clinics 2021; (17(2)):303-313 doi:10.1016/j.hfc.2021.01.003.

    PMID: 33673954
  5. 5

    [The evolving landscape of hypertrophic cardiomyopathy management: a review of the updated AHA/ACC/multisociety guidelines].

    Bertero E, Canepa M, Pieroni M, Olivotto I

    Giornale italiano di cardiologia (2006) 2025; (26(3)):185-194 doi:10.1714/4454.44487.

    PMID: 39998348
  6. 6

    Hypertrophic Cardiomyopathy as a Form of Heart Failure with Preserved Ejection Fraction: Diagnosis, Drugs, and Procedures.

    Banthiya S, Check L, Atkins J

    US cardiology 2024; (18()):e17 doi:10.15420/usc.2023.21.

    PMID: 39508003
  7. 7

    Scar architecture as a structural biomarker of ventricular arrhythmias and sudden cardiac death in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study.

    Francia P, Falasconi G, Musumeci MB, et al.

    European heart journal. Cardiovascular Imaging 2026; (27(3)):400-412 doi:10.1093/ehjci/jeaf297.

    PMID: 41150638
  8. 8

    Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta-Analysis.

    Landsteiner I, Masri A, Saberi S, et al.

    Journal of the American Heart Association 2025; (14(17)):e039551 doi:10.1161/JAHA.124.039551.

    PMID: 40878996
  9. 9

    Role of Exercise Testing in Hypertrophic Cardiomyopathy.

    Rowin EJ, Maron BJ, Olivotto I, Maron MS

    JACC. Cardiovascular imaging 2017; (10(11)):1374-1386 doi:10.1016/j.jcmg.2017.07.016.

    PMID: 29122139
  10. 10

    Multimodality imaging of hypertrophic cardiomyopathy.

    Dong T, Gilliland Y, Kramer CM, et al.

    Progress in cardiovascular diseases 2023; (80()):14-24 doi:10.1016/j.pcad.2023.08.004.

    PMID: 37586654
  11. 11

    The Diagnosis and Treatment of Hypertrophic Cardiomyopathy.

    Möbius-Winkler MN, Laufs U, Lenk K

    Deutsches Arzteblatt international 2024; (121(24)):805-811.

    PMID: 39377928
  12. 12

    Obstruction in Hypertrophic Cardiomyopathy: Many Faces.

    Abbasi M, Ong KC, Newman DB, et al.

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2024; (37(6)):613-625 doi:10.1016/j.echo.2024.02.010.

    PMID: 38428652
  13. 13

    Cardiac troponin I is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.

    Zhou Y, Yu M, Yuan J, et al.

    Heart and vessels 2020; (35(6)):876-885 doi:10.1007/s00380-019-01549-0.

    PMID: 31907598
  14. 14

    Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging for non-sustained ventricular tachycardia and sudden cardiac death in hypertrophic cardiomyopathy: a meta-analysis.

    Siddiqi AK, Maniya MT, Bilen O, et al.

    European radiology 2026; (36(2)):1158-1169 doi:10.1007/s00330-025-11961-y.

    PMID: 40836019
  15. 15

    Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.

    Weng Z, Yao J, Chan RH, et al.

    JACC. Cardiovascular imaging 2016; (9(12)):1392-1402 doi:10.1016/j.jcmg.2016.02.031.

    PMID: 27450876
  16. 16

    Pulmonary Embolism in a Patient With Hypertrophic Obstructive Cardiomyopathy: Think Outside "the Box".

    Wartenweiler M, Dellas Buser T, Joerg L, et al.

    The Canadian journal of cardiology 2021; (37(8)):1275-1277 doi:10.1016/j.cjca.2021.02.019.

    PMID: 33677099
  17. 17

    Conventional cardiopulmonary resuscitation-induced refractory cardiac arrest due to latent left ventricular outflow tract obstruction due to a sigmoid septum: a case report.

    Yamagishi T, Tanabe T, Fujita H, et al.

    Journal of medical case reports 2018; (12(1)):229 doi:10.1186/s13256-018-1767-z.

    PMID: 30122151
  18. 18

    Prognosis of Patients with Hypertrophic Obstructive Cardiomyopathy: A Multicenter Cohort Study with Data-Driven Propensity Score Matching Analysis.

    He Y, Ma H, Sun N, et al.

    Reviews in cardiovascular medicine 2023; (24(9)):267 doi:10.31083/j.rcm2409267.

    PMID: 39076388
  19. 19

    Experiences Implementing a Suite of Decision Aids for Implantable Cardioverter Defibrillators: Qualitative Insights From the DECIDE-ICD Trial.

    Knoepke CE, Wallace BC, Allen LA, et al.

    Circulation. Cardiovascular quality and outcomes 2022; (15(11)):e009352 doi:10.1161/CIRCOUTCOMES.122.009352.

    PMID: 36378770
  20. 20

    Predicting the Future in Hypertrophic Cardiomyopathy.

    Ho CY, Link MS

    Circulation 2018; (137(10)):1024-1026 doi:10.1161/CIRCULATIONAHA.117.032627.

    PMID: 29506995
  21. 21

    Development and piloting of four decision aids for implantable cardioverter-defibrillators in different media formats.

    Wallace BC, Jones J, Masoudi FA, et al.

    Pacing and clinical electrophysiology : PACE 2021; (44(11)):1842-1852 doi:10.1111/pace.14365.

    PMID: 34528271

This page provides general lifestyle and exercise guidelines for living with Hypertrophic Cardiomyopathy (HCM). Always consult your cardiologist to develop a personalized exercise and monitoring plan.

Get notified when new evidence is published on Hypertrophic Cardiomyopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.